Enrichment and Expansion of Mart-1, NY-ESO and WT1 Specifc C…
Emerging
0
Citations0
Refs2014
Year
Search Works
Work Details
- DOI 10.1182/blood.v124.21.2443.2443
- OpenAlex ID W2571548840
- Type Article
- Language EN
- Published 06 Dec 2014
- Volume 124 (21)
- Pages 2443
- Source Blood
- Publisher Elsevier BV
- Countries 1
- Institutions 2
- Added 13 Jan 2017
- Updated 29 Sep 2026
External Links
MENU
0
Enrichment and Expansion of Mart-1, NY-ESO and WT1 Specifc CD8+ T Cells Using Nano-Particle Artificial Antigen Presenting Cells (Nano-aAPCs)
Article 2014 EN
Abstract Background:Harnessing the cytotoxic properties of T cells to destroy tumor cells has been the central goal of anti-cancer immunotherapy. One approach to achieve this goal has been the use adoptive cell transfer (ACT). This method involves the isolation, in vitro manipulation and re-infusion of antigen-specific T cells into cancer patients. This approach has been used to mediate durable re…
0
Citations
0
References
7
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
7 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Juan Carlos Varela | Johns Hopkins Hospital (US) | — |
| 2 | Karlo Perica Corresponding | Johns Hopkins University (US) | |
| 3 | Christian Schuetz Corresponding | Johns Hopkins University (US) | |
| 4 | Joan Glick Bieler Corresponding | Johns Hopkins University (US) | |
| 5 | Carl Haupt Corresponding | Johns Hopkins University (US) | |
| 6 | Mathias Oelke Corresponding | Johns Hopkins University (US) | |
| 7 | Jonathan P. Schneck | Johns Hopkins University (US) |
Related Works
10Data: OpenAlex